Skip to main content
Fig. 9 | BMC Urology

Fig. 9

From: Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signature

Fig. 9

Immune functions and prediction of clinical treatment response. (A) TIDE scores. (B) Differential analysis of tumor microenvironment. (C) Composition of immune cells in two disulfidptosis-score subgroup. (D) The Relative immune infiltration score of 22 immune cells between low- and high-risk groups. (E) Analysis of immune function differences. TIDE, tumor immune dysfunction and exclusion

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us